9MZH image
Deposition Date 2025-01-23
Release Date 2025-07-30
Last Version Date 2025-11-05
Entry Detail
PDB ID:
9MZH
Title:
Cryo-EM structure of the Nipah virus polymerase containing the connecting domain
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.99 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Phosphoprotein
Gene (Uniprot):P/V/C
Chain IDs:A (auth: B), B (auth: C), C (auth: D), D (auth: E), E (auth: G)
Chain Length:759
Number of Molecules:5
Biological Source:Henipavirus nipahense
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:RNA-directed RNA polymerase L
Gene (Uniprot):L
Chain IDs:F (auth: H), G (auth: A)
Chain Length:2270
Number of Molecules:2
Biological Source:Henipavirus nipahense
Ligand Molecules
Primary Citation
Cryo-EM structures of Nipah virus polymerases and high-throughput RdRp assay development enable anti-NiV drug discovery.
Nat Commun 16 6655 6655 (2025)
PMID: 40683863 DOI: 10.1038/s41467-025-61764-4

Abstact

Transcription and replication of the Nipah virus (NiV) are driven by the large protein (L) together with its essential co-factor phosphoprotein (P). L encodes all the viral enzymatic functions, including RNA-dependent RNA polymerase (RdRp) activity, while the tetrameric P is multi-modular. Here, we investigate the molecular mechanism of the NiV polymerase and build tools for anti-NiV drug discovery. We analyze and compare multiple cryo-EM structures of both full-length and truncated NiV polymerases from the Malaysia and Bangladesh strains. We identify two conserved loops in the polyribonucleotidyltransferase (PRNTase) domain of L and the binding between RdRp-PRNTase and CD domains. To further assess the mechanism of NiV polymerase activity, we establish a highly sensitive radioactive-labeled RNA synthesis assay and identify a back-priming activity in the NiV polymerase as well as a fluorescence and luminescent-based non-radioactive polymerase assay to enable high-throughput screening for L protein inhibitors. The combination of structural analysis and the development of both high-sensitive and high-throughput biochemical assays will enable the identification of new direct-acting antiviral candidates for treating highly pathogenic henipaviruses.

Legend

Protein

Chemical

Disease

Primary Citation of related structures